PANAXIA LABS ISRAEL LTD Toevoegen aan een lijst
Inactief instrument
Onderneming Panaxia Labs Israel Ltd TEL AVIV STOCK EXCHANGE
Aandelen
PNAX
IL0011043630
Beleggingsbeheer & Fondsbeheerders
Vakgebied
Verkoop per activiteit
| ILS in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
|---|---|---|---|---|---|
Medical Cannabis Products
97,6
%
| 37 | 94,4 % | 19 | 97,6 % | -48,65% |
Production Services, Storage and Distribution
2,4
%
| 2 | 5,6 % | 0 | 2,4 % | -78,38% |
Verkoop per regio
| ILS in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
|---|---|---|---|---|---|
Israel
53,8
%
| 27 | 67,3 % | 11 | 53,8 % | -60,25% |
Europe
46,2
%
| 13 | 32,7 % | 9 | 46,2 % | -29,84% |
Managers
| Managers | Titel | Leeftijd | Van |
|---|---|---|---|
Dadi Segal
CEO | Chief Executive Officer | 48 | 01-10-19 |
Assi Rotbart
CHM | Chairman | 49 | 01-10-19 |
| Director of Finance/CFO | 66 | 28-12-22 | |
Eran Goldberg
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-10-19 |
Joseph Ginossar
AUD | Comptroller/Controller/Auditor | 65 | 27-05-18 |
Besturend
| Besturend | Titel | Leeftijd | Van |
|---|---|---|---|
Michal Yageel
BRD | Director/Board Member | 54 | 29-12-21 |
Tal Yaron Eldar
BRD | Director/Board Member | 60 | 21-07-16 |
Michal Sapir
BRD | Director/Board Member | 66 | 17-03-22 |
Rinat Gazit
BRD | Director/Board Member | 55 | 31-10-19 |
Assi Rotbart
CHM | Chairman | 49 | 01-10-19 |
Dadi Segal
CEO | Chief Executive Officer | 48 | 01-10-19 |
Rinat Gazit
BRD | Director/Board Member | 60 | 01-10-19 |
Aandelenklasse
| Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
|---|---|---|---|---|---|
| Aandeel A | 1 | 430 240 | 192 660 ( 44,78 %) | 0 | 44,78 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +38,76% | 102 mld. | |
| +1,11% | 100 mld. | |
| +22,75% | 29,13 mld. | |
| -7,45% | 17,8 mld. | |
| +8,31% | 15,86 mld. | |
| +8,28% | 14,81 mld. | |
| -22,02% | 12,22 mld. | |
| +31,15% | 10,72 mld. | |
| +19,53% | 9,27 mld. |
